Cytokines in serum, nasal secretion and exhaled breath condensate during mepolizumab therapy in patients with different phenotypes of severe eosinophilic asthma: A pilot study-Reference-Cited by-同舟云学术

Cytokines in serum, nasal secretion and exhaled breath condensate during mepolizumab therapy in patients with different phenotypes of severe eosinophilic asthma: A pilot study

Published:2022-09-21 Issue:12 Volume:52 Page:1444-1447
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Experimental Allergy

Author:

Nowak‐Jurek Alicja¹,Gajewski Adrian¹,Frachowicz‐Guereirro Karolina¹,Antczak‐Marczak Monika¹,Gulbas Izabela¹,Kowalski Marek Leszek¹,Chałubiński Maciej¹,Wardzyńska Aleksandra¹^ORCID

Affiliation:

1. Department of Immunology and Allergy Medical University of Lodz Lodz Poland

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cea.14231

Reference10 articles.

1. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention 2018. Available from:www.ginasthma.org

2. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

3. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial

4. Airway IL-1β associates with IL-5 production following dust mite allergen inhalation in humans

5. Monoclonal anti-interleukin‐5 treatment suppresses eosinophil but not T‐cell functions

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mepolizumab induced changes in nasal methylome and transcriptome to predict response in asthma;2023-05-19

2. Mepolizumab therapy decreases epithelial‐derived cytokine concentrations in exhaled breath condensates from patients with severe eosinophilic asthma;Clinical & Experimental Allergy;2023-04-13